4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-064914
SVP & Chief Commercial Officer acquired 28,550 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
NORTHCOTT JOHN · SVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-18 | Grant or award : show line 1 in the form | +28,550 | 228,550 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-18 | Grant or award : show line 2 in the form Stock Option | +51,000 | 51,000 | D |
Loading xslF345X03/doc4.xml…